Modithromycin

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameModithromycin
Drug Alias NameEP-013420S-013420EDP-420EP-13420
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsCommunity Acquired Pneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEnanta Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnanta Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsCommunity Acquired Pneumonia

Other Information

ATC CodeN/A
Related LinksKEGG